Redbiotec GmbH, based in Schlieren, Switzerland, produces proteins and genetic materials for biopharma and food companies.
Founded in 2006 and based in Schlieren, Switzerland, Redbiotec GmbH produces essential proteins and genetic materials for the biopharmaceutical and food industries. Its offerings include kappa casein protein for animal-free milk production, and its HSV-2 vaccine program has been outlicensed to Eurocine Vaccines in Sweden. In November 2014 the company raised CHF 1.39 million from Redalpine Venture Partners. Corinne John is the founder and Christian Schaub is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in